Rabbi Menachem Genack, CEO of the O.U.’s kashrut department, said in a statement that Vireo’s medical cannabis products “were developed to alleviate pain and suffering in accordance with the New York State Compassionate Care Act.”

The statement adds, “Using medical cannabis products recommended by a physician should not be regarded as a ‘chet,’ a sinful act, but rather as a mitzvah, an imperative, a commandment.”